Source: International Congress 2016 – In-patient and out-patient COPD management
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Juliana Gjerazi (Fier, Albania), Juliana Gjerazi, Ervisi Rapaj, Teuta Feleqi, Irma Tashi, Jolanda Daka, Majlinda Hoxha, Albana Daka, Anula Bulo, Regina Hasa, Jul Bushati. LATE-BREAKING ABSTRACT: Biomarkres in exacerbations of chronic obstructive pulmonary disease (ECOPD). Eur Respir J 2016; 48: Suppl. 60, 559

Member's Comments

No comment yet.

Related content which might interest you: Impact of comorbidities on chronic obstructive pulmonary disease (COPD) exacerbations in Singapore Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Acute exacerbations of chronic obstructive pulmonary disease: Is it acute exacerbations of chronic cardiopulmonary disease? Source: International Congress 2014 – Comorbidities Year: 2014 Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 The CANT score: Predicting mortality in exacerbations of chronic obstructive pulmonary disease Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016 Malondialdehyde level in chronic obstructive pulmonary disease exacerbations Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort Source: Annual Congress 2013 –The best posters in chronic care Year: 2013 Relevance of hemoglobin A1c and acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Etiologies of exacerbations of the chronic obstructive pulmonary disease in Tunisia Source: Annual Congress 2013 –Lung infections: a clinical point of view Year: 2013 The role of biomarkers in predicting outcomes in acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 LATE-BREAKING ABSTRACT: Predictive factors of frequent exacerbations in mild grade COPD patients Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016 Early phenotypes of chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Different data in COPD Year: 2015 Antibiotics in the exacerbations of severe and very severe chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Association between arterial stiffness and acute exacerbations in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Are re-admissions with acute exacerbation of chronic obstructive pulmonary disease coded correctly? Source: International Congress 2014 – COPD exacerbations Year: 2014 Predictors of readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013 Effects of pulmonary rehabilitation on exacerbation number and severity in people with chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Breathlessness during exacerbation of chronic obstructive pulmonary disease (ECOPD) and recovery Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications Year: 2019 Impact of not planned readmissions due to acute exacerbations of chronic obstructive pulmonary disease Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Emphysematous phenotype is an independent predictor for frequent exacerbation of chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD Year: 2014 7 Years survival of patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 211s Year: 2001